| 1 | 36326 | Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats. | Gastroenterology | 1979 Aug |
1 |
| 2 | 1351726 | The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells. | Biochem Pharmacol | 1992 Jun 9 |
2 |
| 3 | 1358240 | The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells. | Cytokine | 1992 Sep |
1 |
| 4 | 1359744 | Cytokines and platelet-activating factor in human inflamed colonic mucosa. | Agents Actions | 1992 |
1 |
| 5 | 1360533 | PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid. | J Pharm Pharmacol | 1992 Sep |
3 |
| 6 | 1364279 | The oxygen-centered radicals scavenging activity of sulfasalazine and its metabolites. A direct protection of the bowel. | Acta Physiol Hung | 1992 |
2 |
| 7 | 1446859 | Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease. | Gut | 1992 Oct |
2 |
| 8 | 1499439 | Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid. | Dig Dis Sci | 1992 Aug |
2 |
| 9 | 1563100 | IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. | Clin Exp Immunol | 1992 Apr |
1 |
| 10 | 1630544 | Low doses of drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patients with IgA nephropathy: a preliminary noncontrolled trial. | Nephron | 1992 |
2 |
| 11 | 1647912 | Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity. | Clin Exp Rheumatol | 1991 Mar-Apr |
1 |
| 12 | 1685923 | Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245. | Aliment Pharmacol Ther | 1991 Dec |
1 |
| 13 | 1794301 | Release of platelet-activating factor (PAF) from human colon mucosa and its inhibition by 5-aminosalicylic acid. | Drugs Exp Clin Res | 1991 |
5 |
| 14 | 1846838 | 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. | Gut | 1991 Jan |
1 |
| 15 | 1885075 | Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. | Gut | 1991 Aug |
2 |
| 16 | 2155024 | The chlorinating activity of human myeloperoxidase: high initial activity at neutral pH value and activation by electron donors. | Biochim Biophys Acta | 1990 Feb 9 |
2 |
| 17 | 2255590 | Dissolution profiles of mesalazine formulations in vitro. | Pharm Weekbl Sci | 1990 Oct 19 |
1 |
| 18 | 2563347 | Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum. | Gastroenterology | 1989 Mar |
2 |
| 19 | 2574700 | Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils. | Gut | 1989 Nov |
2 |
| 20 | 2867770 | Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites. | Arzneimittelforschung | 1985 |
3 |
| 21 | 2875632 | Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. | Agents Actions | 1986 Jun |
3 |
| 22 | 2877884 | 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa. | Eur J Clin Pharmacol | 1986 |
4 |
| 23 | 2882965 | Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. | Dig Dis Sci | 1987 Jun |
1 |
| 24 | 2883067 | Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity. | Gastroenterology | 1987 Jun |
1 |
| 25 | 2890198 | Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. | Scand J Gastroenterol | 1987 Sep |
3 |
| 26 | 2902897 | Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action? | Br J Rheumatol | 1988 Oct |
1 |
| 27 | 2906888 | Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis. | Digestion | 1988 |
1 |
| 28 | 3017804 | Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. | Gastroenterology | 1986 Oct |
1 |
| 29 | 6121576 | The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. | Br J Clin Pharmacol | 1982 Apr |
2 |
| 30 | 6428914 | Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine. | Eur J Clin Pharmacol | 1984 |
2 |
| 31 | 7496871 | Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases. | Eur J Gastroenterol Hepatol | 1995 Aug |
2 |
| 32 | 7640156 | Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. | Br J Clin Pharmacol | 1995 Apr |
2 |
| 33 | 7815356 | 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells. | J Pharmacol Exp Ther | 1995 Jan |
12 |
| 34 | 7938083 | 5-Aminosalicylic acid inhibits leukotriene B4 omega-hydroxylase activity in human polymorphonuclear leukocytes. | Prostaglandins Leukot Essent Fatty Acids | 1994 Jun |
3 |
| 35 | 8281849 | Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils. | Dig Dis Sci | 1994 Jan |
1 |
| 36 | 8566837 | 5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. | Gut | 1996 Jan |
6 |
| 37 | 8691064 | Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. | J Leukoc Biol | 1996 Jun |
1 |
| 38 | 8862941 | The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells. | Curr Med Res Opin | 1996 |
1 |
| 39 | 9352849 | Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells. | Gastroenterology | 1997 Nov |
4 |
| 40 | 9391781 | A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. | Eur J Gastroenterol Hepatol | 1997 Oct |
1 |
| 41 | 9571233 | Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells. | Drug Metab Dispos | 1998 May |
3 |
| 42 | 9577349 | Expression of arylamine N-acetyltransferase in human intestine. | Gut | 1998 Mar |
5 |
| 43 | 9780130 | Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions. | Ther Drug Monit | 1998 Oct |
1 |
| 44 | 9885444 | Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. | Int J Hematol | 1998 Dec |
2 |
| 45 | 9893931 | Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine. | Arzneimittelforschung | 1998 Dec |
5 |
| 46 | 9895376 | 5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells. | Gut | 1999 Feb |
4 |
| 47 | 9895377 | Anti-inflammatory drugs and endothelial cell adhesion molecule expression in murine vascular beds. | Gut | 1999 Feb |
2 |
| 48 | 10029619 | Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. | Gastroenterology | 1999 Mar |
8 |
| 49 | 10194945 | [Clinical effect of various 5-ASA preparations in ulcerative colitis]. | Med Klin (Munich) | 1999 Feb 15 |
3 |
| 50 | 10422769 | Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs. | Eur J Pharmacol | 1999 Jun 18 |
1 |